{"id":"W3096911669","doi":"10.1182/blood-2020-142182","title":"Single Centre, Retrospective Study to Evaluate Treatment Outcomes Following Tyrosine Kinase Inhibitor for Chronic Gvhd Treatment Including Ruxolitinib, Ibrutinib and Imatinib","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Ruxolitinib; Ibrutinib; Internal medicine; Tyrosine-kinase inhibitor; Imatinib; Oncology; Graft-versus-host disease; Hematopoietic stem cell transplantation; Janus kinase inhibitor; Transplantation; Pharmacology; Tofacitinib; Gastroenterology; Cancer; Leukemia; Myelofibrosis; Bone marrow; Chronic lymphocytic leukemia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008162942,0.0003315137,0.0007806516,0.0008966121,0.0006367347,0.0005477478,0.0002909487,0.0004136423,0.00210454],"category_scores_gemma":[0.001386032,0.0003163232,0.0005879147,0.00102095,0.0004184495,0.0004223826,0.0004396644,0.0003504567,0.0004691055],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006065394,"about_ca_system_score_gemma":0.0006913168,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002101052,"about_ca_topic_score_gemma":0.002963287,"domain_scores_codex":[0.999148,0.000152501,0.0001478262,0.0002893991,0.0001502719,0.0001119046],"domain_scores_gemma":[0.9981585,0.0002245578,0.000961981,0.0001433801,0.0002022101,0.0003093854],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0005149457,0.0001287512,0.9963025,0.00006133371,0.00007812009,0.0005915392,0.0001423521,0.00002697449,0.0003556693,0.00001850522,0.00008864736,0.001690615],"study_design_scores_gemma":[0.0001118075,0.003417523,0.9882951,0.00003636517,0.0002113502,0.005291072,0.0006633539,0.0001232601,0.0003363465,0.00003592026,0.001460126,0.00001778643],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.998244,0.000643166,0.0001415972,0.00001353259,0.00000839109,0.0001239047,0.0003158677,0.000002794434,0.0005067018],"genre_scores_gemma":[0.9987385,0.0002060314,0.0001919818,0.00006086851,0.00002621065,0.00007601993,0.0005012435,0.000002848319,0.0001962755],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00210454,"threshold_uncertainty_score":0.007040441,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07223258988129425,"score_gpt":0.3598346977992248,"score_spread":0.2876021079179305,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}